MPMaría Teresa Carrillo de la Peña

María Teresa Carrillo de la Peña

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


María Teresa Carrillo de la Peña has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Determination of central pain modulation biomarkers to characterise patients with cancer and refractory pain: protocol for a cross-sectional study

    by Lara Rubal-Otero, Natalia Martinez-Rodriguez, Margarita Álvarez-Rodríguez, Alberto González-Villar, María T Carrillo-De-La-Peña

    Introduction: Pain is one of the most prevalent and disabling oncological symptoms, but its underlying mechanisms remain poorly understood. Most research has focused on peripheral mechanisms, while central pain modulation has been poorly explored. Quantitative sensory testing (QST) and electroencephalography (EEG) provide non-invasive approaches to assess central pain processing but the evidence using those approaches in patients with cancer is limited. This study protocol aims to identify and validate central biomarkers of pain perception and modulation (QST and EEG) and the role of moderator variables to better characterise patients with cancer pain. Methods and analysis: This study protocol describes a multicentre, cross-sectional, case–control study that will include a minimum of 470 ambulatory patients with cancer, including 313 with oncological pain and 157 without pain. Participants will be recruited taking into account age, sex and cancer type (lung, breast, pancreas, prostate and colon). All participants will perform a single face-to-face assessment that will include sociodemographic and clinical data, QST (pain modulation and inhibitory pain mechanisms, temporal summation and pain thresholds) and EEG (at rest and in response to thermal nociceptive stimuli) assessment and administration of questionnaires (pain, quality of life, fatigue, sleep, mood, etc). Statistical modelling and machine learning approaches will be used to investigate pain modulation biomarkers, their association with age and sex and to characterise patients with cancer pain. Ethics and dissemination: This study has received approval from all local ethics committees of the participating clinical sites. Results will be disseminated through high-impact peer-reviewed journals, international conferences and open data repositories, in compliance with General Data Protection Regulation (GDPR) and FAIR (Findable, Accessible, Interoperable, and Reusable) principles, and following the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement for observational case–control studies. Trial registration number: ISRCTN35887998 .

  • Open Access

    Longitudinal Changes in Somatosensory Function and Their Association with Pain Trajectory Groups in a Portuguese Cancer Center Cohort

    by Ana Sofia Martins, Mariana Ferreira, Cláudia Vieira, Otília Romano, Rosário Rodrigues, Diana Ramada, Catarina Castro, Ana Paula Moreira, María Teresa Carrillo-De-La-Peña, Ana Luísa Teixeira, et al.

    Background: Cancer-related pain involves complex peripheral and central mechanisms. Quantitative sensory testing (QST) assesses somatosensory function and provides insights into pain mechanisms. However, longitudinal evidence in oncological populations remains limited. This study investigated longitudinal changes in somatosensory function and their relationship with pain intensity and pain trajectory groups in a Portuguese cancer cohort. Methods: This longitudinal study was conducted within the international PAINLESS project and included participants from the Portuguese clinical unit. A total of 56 cancer patients were assessed at diagnosis (baseline, T0), before treatment, and at 6-month follow-up (T6). Pain intensity was measured using the Numeric Rating Scale (NRS), and somatosensory function was assessed using standardized thermal QST, including heat pain threshold (HPT), cold detection threshold (CDT), cold pain threshold (CPT), temporal summation of pain (TSP), and conditioned pain modulation (CPM). Non-parametric analyses evaluated longitudinal changes, correlations between pain and QST measures, differences according to clinically relevant pain (NRS < 4 vs. ≥ 4), and differences across clinically meaningful pain trajectory groups. Results: Thermal sensory thresholds changed significantly, with decreased HPT (p = 0.025) and increased CDT (p < 0.001) and CPT (p = 0.005). At T0, pain intensity was negatively correlated with CDT (rs = − 0.371, p = 0.009), whereas at T6 it was positively correlated with CPT (rs = 0.401, p = 0.006). Longitudinal changes in pain intensity were also associated with changes in CPT (rs = 0.337, p = 0.029). Trajectory analysis demonstrated significant baseline CDT differences across pain trajectory groups (p = 0.028), with higher CDT values in the pain increase group than in the persistent pain group (adjusted p = 0.035). No significant longitudinal changes were observed in central pain modulatory measures (TSP and CPM). Conclusions: Altered thermal sensory processing, particularly cold-related measures, was associated with pain intensity and trajectories during the first six months after diagnosis. While central pain modulation remained stable, CDT and CPT showed consistent relationships with clinically relevant pain outcomes. These findings support the potential utility of thermal QST for characterizing sensory profiles and pain trajectory groups in cancer-related pain; being important, further longitudinal studies are needed to determine the predictive value of these measures.

  • Open Access

    Transcranial electric stimulation in chronic pain: Effects on quality of life, physical function, activity and clinical status

    by Antonio Gil‐Ugidos, María López‐Corchón, Gavriella Τsiarleston, Víctor Segura‐Jiménez, María Teresa Carrillo‐De‐La‐Peña

    Transcranial electric stimulation represents a promising non‐invasive neuromodulatory technique targeting maladaptive nociplastic changes in chronic pain (CP) with analgesic effects. However, its impact beyond pain reduction on broader outcomes such as quality of life (QoL) and physical function remains unclear. This study aimed to evaluate the impact of two home‐based transcranial electric stimulation modalities, using direct (tDCS) or alternating current (tACS), on improving QoL, addressing comorbid symptoms and enhancing physical function and engagement in physical activity in individuals with CP. In a double‐blind randomized controlled trial, 120 CP participants (97 females, 49.5 ± 8.7 years) received 15 sessions of home‐based tDCS over the primary motor cortex (M1), tACS over the dorsolateral prefrontal cortex (DLPFC), or sham stimulation. A multidimensional assessment was used before, during and after the treatment, combining subjective measures (QoL, mood, fatigue, sleep quality, perceived physical fitness) and objective metrics (field‐based physical fitness tests, accelerometry). Compared with the sham group, both active tES modalities significantly improved QoL, with no differences between M1‐tDCS (MD=‐7.7; p < .001) and DLPFC‐tACS (MD=‐7.8; p < .001). However, symptom‐specific domains showed no differential effects compared with sham (all p > .05). All groups exhibited increased physical activity during the intervention and improvements in physical function after the intervention ( p < .001), suggesting the contribution of contextual factors. Our findings highlight the potential of home‐based tES to enhance QoL in CP patients. The lack of differences between intervention groups in domain‐specific outcomes (mood, fatigue, sleep) and physical activity underscores the complexity of the therapeutic response, likely influenced by neurophysiological, behavioural, and contextual mechanisms.

  • Open Access

    A novel tool to assess self-reported cancer-related cognitive impairment: the ONCOFOG questionnaire (OFQ)

    by Cristina Salgado-Blanco, Diego Pinal, Lara Rubal-Otero, Margarita Alvarez-Rodríguez, María Teresa Carrillo de la Peña

    Objective: Self-report questionnaires are useful for detecting cancer-related cognitive impairment (CRCI), but current options present shortcomings in terms of content and length. The ONCOFOG questionnaire (OFQ) was designed to provide a brief, comprehensive tool for detecting self-reported CRCI, following CRCI management guidelines recommendations.Method: The OFQ has three parts: 1) screening on the self-perception of CRCI; 2) 15 items on cognitive difficulties; and 3) CRCI impact. Spanish adult survivors answered the OFQ and tests of cognitive complaints (PROMIS-CF 8a), anxiety (GAD-7), depression (PHQ-9) and quality of life (QoL-VAS). The factor structure, reliability and validity of the OFQ (Part 2) were analysed.Results: 261 participants completed the baseline assessment and 112 the retest (one month later). Two hundred and seven (79%) self-reported CRCI and over 70% reported a significant impact on daily life. The OFQ showed a unidimensional structure, with a factor explaining 76% of data variance. Internal consistency (MacDonald’s ω = .972) and test-retest reliability (r = .871, p < .001) were excellent, as were criterion (PROMIS-CF 8a: r = -.902, p < .001) and construct validity (PHQ-9: r = .693; GAD-7: r = .556; QoL-VAS: r = -.405, all p < .001). A cut-off score of 33 in Part 2 significantly predicted self- reported-CRCI. Conclusions: The OFQ is a brief and comprehensive tool useful for detecting self-reported CRCI and its impact in both clinical practice and research. Further investigation with other survivor populations, longer tests-retest periods and culturally adaptation to other languages are needed. Implications for Nursing Practice: The OFQ can be used in clinical settings to identify survivors who may benefit from cognitive intervention.

  • Open Access

    Efficacy of Cognitive Training for Treating Cancer-related Cognitive Impairment: Systematic Review and Meta-analysis by Cognitive Domain

    by Cristina Salgado-Blanco, Ana F. Oliveira, María Teresa Carrillo-De-La-Peña, Carina Fernandes

    Cognitive Training (CT) is proposed to improve cancer-related cognitive impairment (CRCI), but its effect on objective cognition remains unclear. This systematic review and meta-analysis (PROSPERO ID: CRD42023426761) aimed to examine the efficacy of CT on objective CRCI using neuropsychological tests categorised into cognitive domains following international classifications. Secondary objectives were to assess CT effects on self-reported variables. A systematic search was conducted in PubMed, PsycINFO and Cochrane Library (last search in May 2024). Controlled trials performing CT and reporting neuropsychological outcomes were included. Risk of bias was assessed with RoB-2 and certainty of evidence with the GRADE approach. Hedges’ g at post-intervention was the primary outcome of the multivariate meta-analysis, calculated as the standardized mean difference between groups at post-intervention. Hedges´ g at pre-intervention was included as a fixed covariate. Fifteen studies were included in the systematic review and 12 in the meta-analysis (control group n = 507; intervention group n = 578). The meta-analysis showed a small, significant effect of CT on executive functioning (Hedges’ g = 0.15, 95% CI [0.00, 0.29], p = .047). This result warrants cautious interpretation due to low-quality evidence. No significant effects were found in other cognitive domains or self-reported indices. Although these results contrast with previous meta-analyses, this study includes a larger dataset, enhancing the robustness of the results, and introduces a novel analysis strategy by grouping neuropsychological tests according to international classifications. In conclusion, CT shows a small benefit for executive functioning in CRCI, but high-quality studies are needed to confirm its efficacy.


  • Open Access

    Conditioned Pain Modulation (CPM) Paradigms: Reliability and Relationship With Individual Characteristics

    by Antonio Gil-Ugidos, Lara Rubal-Otero, Alberto González-Villar, María Teresa Carrillo-De-La-Peña


  • Open Access

    The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients?

    by Maria Carla Gerra, Cristina Dallabona, Matteo Manfredini, Rocco Giordano, Camilla Capriotti, Alberto González-Villar, Yolanda Triñanes, Lars Arendt-Nielsen, Maria Teresa Carrillo-De-La-Peña

    The single-nucleotide polymorphism (SNP) rs4680 in the catechol-O-methyltransferase gene ( COMT ) is a missense variant (Val158Met) associated with altered activity of the COMT enzyme and suggested as a predictive feature for developing some chronic pain conditions. However, there are controversial results on its role in fibromyalgia (FM). Here, the SNP Val158Met was analyzed in 294 FM patients (without comorbidities) and 209 healthy controls (without chronic pain). The concurrent impact of Val158Met genotypes and FM comorbid disorders (depression and sleep impairment) on FM risk were tested. In addition, the genotypic distribution of FM patients in relation to pain intensity was evaluated. The G allele (Val) resulted in being more represented in the FM group (57.8%) compared with the control group (48.8%; P = 0.037). Logistic regression highlighted that having the G/G (Val/Val) homozygous genotype was associated with 2 times higher risk of having FM compared with the A/A (Met/Met) carriers ( P = 0.038), whereas depression and sleep impairment increased FM risk by 12 and 8 times, respectively ( P < 0.001). However, considering only the FM patient group, the A/A homozygous genotype was significantly associated with severe pain intensity ( P = 0.007). This study highlighted associations between the SNP Val158Met and both FM and pain intensity, suggesting a link between dopaminergic dysfunction and vulnerability to chronic pain. Further studies should explore this SNP in FM patients in conjunction with COMT enzymatic activity and other symptoms connected with the dopaminergic system such as depression or sleep impairment.


  • Open Access

    Temporal summation of second pain is affected by cognitive load

    by Lara Rubal‐Otero, Antonio Gil‐Ugidos, Alberto Jacobo González Villar, María Teresa Carrillo‐De‐La‐Peña

    This work attempted to clarify the interaction of cognition and pain sensitization during a paradigm of Temporal Summation of Second Pain (TSSP). We analyzed pain ratings and electroencephalographic (EEG) activity obtained from 21 healthy participants during the presentation of four experimental conditions that differed in the manipulation of attention to painful stimuli or working memory load (Attention to hand & TSSP; 0‐back & TSSP (low cognitive load); 2‐back & TSSP (high cognitive load); 2‐back (without pain)). We found that the TSSP was reduced when the attention was diverted and the cognitive load increased, and this reduction was accompanied by higher midfrontal theta activity and lower posterior alpha and central beta activity. Although it is well established that TSSP is a phenomenon that occurs at the spinal level, here we show that it is also affected by supraspinal attentional mechanisms. Delivery of painful repeated stimuli did not affect the performance of the 2‐back task but was associated with smaller amplitudes of attentional event‐related potentials (ERPs) after standard stimuli (not the target). The study of brain activity during TSSP allowed to clarify the role of top‐down attentional modulation in pain sensitization processes. Results contribute to a better understanding of cognitive dysfunction in pain conditions and reinforce the use of therapeutic strategies based on distracting attention away from pain.


  • Open Access

    Correction to: Active and sham transcranial direct current stimulation (tDCS) improved quality of life in female patients with fibromyalgia

    by N. Samartin-Veiga, A. J. González-Villar, M. Pidal-Miranda, A. Vázquez-Millán, M. T. Carrillo-De-La-Peña